Richard A Anderson Selected Research

Cadherins (E-Cadherin)

1/2023	Regulation of Cell Adhesion and Migration via Microtubule Cytoskeleton Organization, Cell Polarity, and Phosphoinositide Signaling.
9/2012	PIP2 signaling, an integrator of cell polarity and vesicle trafficking in directionally migrating cells.
6/2012	Multiple post-translational modifications regulate E-cadherin transport during apoptosis.
12/2010	E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation.
1/2010	Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer.
1/2008	Tracking the transport of E-cadherin to and from the plasma membrane.
1/2007	Type I gamma phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with mu 1B adaptin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard A Anderson Research Topics

Disease

54	Neoplasms (Cancer) 10/2023 - 08/2002
24	Insulin Resistance 01/2021 - 12/2003
20	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2007
16	Type 2 Diabetes Mellitus (MODY) 07/2013 - 08/2003
13	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2023 - 02/2008
11	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 09/2006
11	Inflammation (Inflammations) 11/2012 - 01/2006
10	Adenocarcinoma 01/2011 - 02/2004
8	Infertility (Sterility) 01/2022 - 10/2014
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 12/2003
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2012 - 12/2006
6	Azoospermia 12/2019 - 09/2004
5	Mitochondrial Diseases (Mitochondrial Disease) 11/2023 - 04/2009
5	Body Weight (Weight, Body) 01/2021 - 12/2007
5	Obesity 05/2015 - 12/2003
4	Carcinogenesis 01/2020 - 02/2004
4	Primary Ovarian Insufficiency 03/2016 - 10/2010
3	Male Infertility (Male Sterility) 01/2024 - 01/2021
3	Glioma (Gliomas) 01/2021 - 02/2014
3	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 02/2011
3	Weight Gain 12/2018 - 05/2010
3	Hemorrhage 11/2015 - 02/2014
3	Brain Edema (Cerebral Edema) 10/2015 - 06/2010
2	Premature Menopause 10/2023 - 01/2018
2	Hyperandrogenism 03/2023 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2007
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 10/2018
2	Leukemia 11/2021 - 10/2021
2	Premature Birth (Birth, Premature) 10/2021 - 01/2021
2	Spontaneous Abortion (Miscarriage) 01/2021 - 03/2020
2	Hot Flashes 12/2020 - 01/2018
2	Leiomyoma (Uterine Fibroids) 03/2020 - 01/2014
2	Amenorrhea 01/2020 - 11/2017
2	Heart Failure 11/2019 - 03/2002
2	Ovarian Hyperstimulation Syndrome 12/2018 - 03/2012

Drug/Important Bio-Agent (IBA)

20	Insulin (Novolin)FDA Link 10/2016 - 12/2003
18	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2003
17	Hormones (Hormone)IBA 01/2022 - 02/2006
17	Proteins (Proteins, Gene)FDA Link 05/2021 - 12/2004
16	PolyphenolsIBA 03/2019 - 12/2005
11	LipidsIBA 12/2016 - 12/2003
10	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2024 - 01/2010
10	Messenger RNA (mRNA)IBA 01/2013 - 09/2005
9	Testosterone (Sustanon)FDA Link 01/2022 - 09/2006
9	FructoseIBA 01/2018 - 01/2007
8	AntioxidantsIBA 01/2011 - 08/2003
7	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2014
7	Cadherins (E-Cadherin)IBA 01/2023 - 01/2007
7	CholesterolIBA 10/2016 - 12/2003
7	TeaIBA 10/2015 - 01/2007
7	prostaglandin F2alpha receptorIBA 01/2011 - 02/2004
7	ChromiumIBA 05/2010 - 12/2003
7	ProstaglandinsIBA 01/2010 - 12/2004
6	Neurokinin BIBA 01/2021 - 02/2015
6	Blood Glucose (Blood Sugar)IBA 01/2021 - 12/2003
6	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2020 - 01/2010
6	EnzymesIBA 01/2016 - 09/2009
5	KisspeptinsIBA 01/2021 - 01/2010
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2003
5	GonadotropinsIBA 01/2020 - 09/2004
5	ErbB Receptors (EGF Receptor)IBA 01/2019 - 02/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 09/2005
4	Phosphotransferases (Kinase)IBA 04/2024 - 01/2010
4	AndrogensIBA 03/2023 - 10/2011
4	SteroidsIBA 01/2021 - 01/2006
4	Estrogens (Estrogen)FDA Link 01/2020 - 01/2003
4	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2019 - 09/2012
4	Phosphates (Orthophosphate)IBA 10/2016 - 01/2010
4	LDL CholesterolIBA 10/2016 - 12/2003
4	Lipoproteins (Lipoprotein)IBA 11/2012 - 01/2008
4	thiamine triphosphorate (TTP)IBA 03/2011 - 01/2007
4	DinoprostIBA 09/2009 - 02/2004
3	Anti-Mullerian HormoneIBA 04/2022 - 09/2011
3	Oncogene Proteins (Oncogene Protein)IBA 05/2021 - 01/2015
3	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2021 - 03/2011
3	AntralIBA 01/2019 - 03/2012
3	LigandsIBA 01/2016 - 12/2009
3	HDL CholesterolIBA 10/2011 - 12/2003
3	CalcineurinIBA 01/2011 - 12/2009
3	Prostaglandins FIBA 12/2009 - 02/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2009 - 01/2007
3	picolinic acid (chromium picolinate)IBA 04/2009 - 12/2007
3	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2009 - 06/2005
2	Inositol PhosphatesIBA 04/2024 - 02/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2014
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 11/2016
2	Neurokinin-3 ReceptorsIBA 01/2022 - 01/2018
2	LeptinIBA 01/2021 - 01/2010
2	inhibin BIBA 01/2021 - 09/2011
2	Peptides (Polypeptides)IBA 01/2020 - 02/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2014
2	human KISS1 proteinIBA 11/2017 - 07/2013

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 04/2022 - 01/2006
21	Therapeutics 01/2023 - 03/2002
8	Aftercare (After-Treatment) 01/2024 - 08/2002
6	Radiotherapy 01/2022 - 10/2011
4	Contraception (Birth Control) 01/2024 - 02/2015
4	Adjuvant Chemotherapy 01/2023 - 10/2010
4	Stents 08/2016 - 11/2009